INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 457m ago
HOUSE PTR57m ago
SEC 13F57m ago
ROBINHOOD CHAIN56m ago
FM
Corporate insider

Friedberg Ezra M

DirectorCIK 0001679440

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 5
Max Insider Score20
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$12K
558 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Pelthos Therapeutics Inc.Director · Apr 6, 2026
17
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL
$14K
534 sh
Jul 2, 2026
Jul 7, 2026
traded Jul 2, 2026
+5d
SEC FORM 4

Evidence

17
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$656
24 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC FORM 4

Evidence

20
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$6,010
293 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC FORM 4

Evidence

20
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$5,661
265 sh
Apr 2, 2026Apr 6, 2026
traded Apr 2, 2026
+4dSEC FORM 4

Evidence